FINANCIALS

LGND Ligand Pharmaceuticals Inc 886163

Income Statement
Revenue	lgnd-20241231	167,133,000
Net Income	lgnd-20241231	-4,032,000
Profit Margin		-2.41%

Balance Sheet
Current Assets	331,559,000
Assets	941,774,000
Current Liabilities	37,112,000
Liabilities	111,335,000
Equity	830,439,000
Shares Out	18,269,000

Cash Flow Statement
Operating Cash Flow	97,047,000
Investing Cash Flow	-143,664,000

Market Analysis
Market Cap	1,916,584,600
Price	109.99
BVPS	45.46
PB	2.37
EPS	2.22
PE	47.15
PS	2.87
FCF	-46,617,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view LGND documents filed with the SEC.

LGND Filings Clear

View A List of Tickers